News Invest in NHS to boost life sciences, says pharma body Make NHS best place to research and launch drugs, says ABPI.
News Life Sciences at heart of UK’s new Industrial Strategy No guarantee of funding for new medicines funding - which is being squeezed again
News UK MHRA green lights AbbVie’s ELAHERE for ovarian cancer AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibo
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
